Evidence map›Paper›PMID 33758871›Full record

ArticlemedRxiv : the preprint server for health sciences2021

High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.

Carla Cerami, Tyler Rapp, Feng-Chang Lin, Kathleen Tompkins, Christopher Basham, Meredith S Muller, Maureen Whittelsey, Haoming Zhang, Srijana B Chhetri, Judy Smith and 11 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 29 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 2 countries.

Carla CeramiMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, The Gambia.
Tyler RappInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Feng-Chang LinGillings School of Global Public Health, University of North Carolina, Chapel Hill, NC USA.
Kathleen TompkinsInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Christopher BashamInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Meredith S MullerInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Maureen WhittelseyInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Haoming ZhangGillings School of Global Public Health, University of North Carolina, Chapel Hill, NC USA.
Srijana B ChhetriInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Judy SmithInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Christy LitelInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Kelly LinInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Mehal ChuriwalInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Salman KhanDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Faith ClamanInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Rebecca RubinsteinGillings School of Global Public Health, University of North Carolina, Chapel Hill, NC USA.
Katie MollanGillings School of Global Public Health, University of North Carolina, Chapel Hill, NC USA.
David WohlInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Lakshmanane PremkumarDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Jonathan J JulianoInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
Jessica T LinInstitute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC USA.
University of North Carolina at Chapel Hill · USMRC Unit the Gambia · GM

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Medical Research Council MR/R023360/1NCATS NIH HHS UL1 TR002489
6 · The paper itself

Abstract

Background: Few prospective studies of SARS-CoV-2 transmission within households have been reported from the United States, where COVID-19 cases are the highest in the world and the pandemic has had disproportionate impact on communities of color. Methods and Findings: This is a prospective observational study. Between April-October 2020, the UNC CO-HOST study enrolled 102 COVID-positive persons and 213 of their household members across the Piedmont region of North Carolina, including 45% who identified as Hispanic/Latinx or non-white. Households were enrolled a median of 6 days from onset of symptoms in the index case. Secondary cases within the household were detected either by PCR of a nasopharyngeal (NP) swab on study day 1 and weekly nasal swabs (days 7, 14, 21) thereafter, or based on seroconversion by day 28. After excluding household contacts exposed at the same time as the index case, the secondary attack rate (SAR) among susceptible household contacts was 60% (106/176, 95% CI 53%-67%). The majority of secondary cases were already infected at study enrollment (73/106), while 33 were observed during study follow-up. Despite the potential for continuous exposure and sequential transmission over time, 93% (84/90, 95% CI 86%-97%) of PCR-positive secondary cases were detected within 14 days of symptom onset in the index case, while 83% were detected within 10 days. Index cases with high NP viral load (>10^6 viral copies/ul) at enrollment were more likely to transmit virus to household contacts during the study (OR 4.9, 95% CI 1.3-18 p=0.02). Furthermore, NP viral load was correlated within families (ICC=0.44, 95% CI 0.26-0.60), meaning persons in the same household were more likely to have similar viral loads, suggesting an inoculum effect. High household living density was associated with a higher risk of secondary household transmission (OR 5.8, 95% CI 1.3-55) for households with >3 persons occupying <6 rooms (SAR=91%, 95% CI 71-98%). Index cases who self-identified as Hispanic/Latinx or non-white were more likely to experience a high living density and transmit virus to a household member, translating into an SAR in minority households of 70%, versus 52% in white households (p=0.05). Conclusions: SARS-CoV-2 transmits early and often among household members. Risk for spread and subsequent disease is elevated in high-inoculum households with limited living space. Very high infection rates due to household crowding likely contribute to the increased incidence of SARS-CoV-2 infection and morbidity observed among racial and ethnic minorities in the US. Quarantine for 14 days from symptom onset of the first case in the household is appropriate to prevent onward transmission from the household. Ultimately, primary prevention through equitable distribution of effective vaccines is of paramount importance.

Identifiers

PMID33758871
PMCPMC7987030
OpenAlexW3135521689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.